News & Events about Eiger Biopharmaceuticals Inc.
Ticker Report
7 months ago
Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR Get Rating) was the recipient of a large increase in short interest in April. As of April 15th, there was short interest totalling 2,710,000 shares, an increase of 9.3% from the March 31st total of 2,480,000 shares. Based on an average daily ...
Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR Get Rating) saw a large increase in short interest in the month of April. As of April 15th, there was short interest totalling 2,710,000 shares, an increase of 9.3% from the March 31st total of 2,480,000 shares. Based on an average daily volume of ...
Thinking about buying stock in Bit Digital, Cipher Mining, Eiger Biopharmaceuticals, Eos Energy, or Bitfarms? Thinking about buying stock in Bit Digital, Cipher Mining, Eiger Biopharmaceuticals, Eos Energy, or Bitfarms? PR Newswire NEW YORK, April 13, 2023 NEW YORK, April 13, 2023 /PRNewswire...
Globe Newswire
9 months ago
PHILADELPHIA, March 06, 2023 (GLOBE NEWSWIRE) -- Investor protection law firm Kaskela Law LLC announces that it is investigating Eiger BioPharmaceuticals, Inc. (Eiger or the Company) (NASDAQ: EIGR) on behalf of the Companys long-term stockholders. Recently a shareholder class action complaint was ...
FINAL DEADLINE ALERT: The Schall Law Firm Encourages Investors in Eiger BioPharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm FINAL DEADLINE ALERT: The Schall Law Firm Encourages Investors in Eiger BioPharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm PR Newswire LOS...